Please join our staff as we participate or present in the following oral and poster presentations at the 2016 ASH Annual Meeting
Please join our staff as we participate or present in the following oral and poster presentations at the 2016 ASH Annual Meeting
Study suggests re-examining eligibility criteria for randomized controlled trials of hematologic malignancies.
Takeaways from Cleveland Clinic’s hematology/medical oncology experts
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Molecular data enhance traditional scoring systems
Research improving myelodysplastic syndromes treatment
Complex karyotypes, TET2 mutations lower survival rates
Cleveland Clinic researchers warn against overtreatment
Insurance data analysis uncovers real-world behaviors
Response in patient subgroups shows promise, however